Allogeneic marrow transplantation.
Publication
, Journal Article
Sullivan, KM; Storb, R
Published in: Cancer Invest
1984
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.
Duke Scholars
Published In
Cancer Invest
DOI
ISSN
0735-7907
Publication Date
1984
Volume
2
Issue
1
Start / End Page
27 / 38
Location
England
Related Subject Headings
- Transplantation, Homologous
- Transplantation Immunology
- Oncology & Carcinogenesis
- Leukemia, Myeloid
- Leukemia, Lymphoid
- Leukemia
- Immunosuppression Therapy
- Immunologic Deficiency Syndromes
- Humans
- Histocompatibility Testing
Citation
APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., & Storb, R. (1984). Allogeneic marrow transplantation. Cancer Invest, 2(1), 27–38. https://doi.org/10.3109/07357908409020284
Sullivan, K. M., and R. Storb. “Allogeneic marrow transplantation.” Cancer Invest 2, no. 1 (1984): 27–38. https://doi.org/10.3109/07357908409020284.
Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest. 1984;2(1):27–38.
Sullivan, K. M., and R. Storb. “Allogeneic marrow transplantation.” Cancer Invest, vol. 2, no. 1, 1984, pp. 27–38. Pubmed, doi:10.3109/07357908409020284.
Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest. 1984;2(1):27–38.
Published In
Cancer Invest
DOI
ISSN
0735-7907
Publication Date
1984
Volume
2
Issue
1
Start / End Page
27 / 38
Location
England
Related Subject Headings
- Transplantation, Homologous
- Transplantation Immunology
- Oncology & Carcinogenesis
- Leukemia, Myeloid
- Leukemia, Lymphoid
- Leukemia
- Immunosuppression Therapy
- Immunologic Deficiency Syndromes
- Humans
- Histocompatibility Testing